Article Versions Notes

Krutilina RI, Hartman KL, Oluwalana D, Playa HC, Parke DN, Chen H, Miller DD, Li W, Seagroves TN. Sabizabulin, a Potent Orally Bioavailable Colchicine Binding Site Agent, Suppresses HER2+ Breast Cancer and Metastasis. Cancers. 2022; 14(21):5336. https://doi.org/10.3390/cancers14215336

Krutilina, Raisa I., Kelli L. Hartman, Damilola Oluwalana, Hilaire C. Playa, Deanna N. Parke, Hao Chen, Duane D. Miller, Wei Li, and Tiffany N. Seagroves. 2022. "Sabizabulin, a Potent Orally Bioavailable Colchicine Binding Site Agent, Suppresses HER2+ Breast Cancer and Metastasis" Cancers 14, no. 21: 5336. https://doi.org/10.3390/cancers14215336

Krutilina, R. I., Hartman, K. L., Oluwalana, D., Playa, H. C., Parke, D. N., Chen, H., Miller, D. D., Li, W., & Seagroves, T. N. (2022). Sabizabulin, a Potent Orally Bioavailable Colchicine Binding Site Agent, Suppresses HER2+ Breast Cancer and Metastasis. Cancers, 14(21), 5336. https://doi.org/10.3390/cancers14215336